top of page
Kickstart a Healthier Lifestyle With Our Weight Loss Plan
Role of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists in Management of Obesity
​
This article looks at the effectiveness of GLP-1 receptor agonists for weight loss as a primary or secondary treatment outcome.
As a class, GLP-1 receptor agonists have a generally more favourable safety profile than several other antiobesity agents; transient, mild-to-moderate gastrointestinal symptoms were the most frequently reported adverse effects in clinical trials.
Read the full article below.
bottom of page